Mark G. Lebwohl, MD, Named President-Elect of the American Academy of Dermatology
Source Newsroom: Mount Sinai Medical Center
Contact: Mount Sinai Newsroom / (212) 241-9200 / NewsMedia@mssm.edu
Newswise — (NEW YORK – March 27) Mark G. Lebwohl, MD, was named President-elect of the American Academy of Dermatology (AAD) during the last day of the annual meeting on March 25. The AAD is the world’s largest dermatologic society, representing more than 17,000 physicians specializing in the diagnosis and medical, surgical, and cosmetic treatment of skin, hair, and nail conditions. He will hold the office of president for one year.
“My position at the AAD will allow me to serve as an even more effective advocate for our patients,” said Dr. Lebwohl, Sol and Clara Kest Professor of Dermatology
and Chair of the Kimberly and Eric J. Waldman Department of Dermatology
at the Icahn School of Medicine at Mount Sinai. “Quality patient care will be the focus of my presidency.”
Dr. Lebwohl completed residencies in internal medicine and dermatology at Mount Sinai and has been practicing dermatology since 1983. He has transformed Mount Sinai's Dermatology Department from a small group with a faculty of two, to one of the largest in the nation with more than 40 full-time faculty members and nearly 250 voluntary faculty members.
“Dr. Lebwohl has devoted his career to developing and testing therapeutic dermatologic treatments as well as treating patients,” said Dennis Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, President for Academic Affairs, Mount Sinai Health System. “He helped pioneer and introduce the use of topical agents that harness the immune system to treat precancerous skin lesions and skin cancers; the use of topical calcineurin inhibitors for psoriasis; and many targeted biologic therapies for psoriasis, vitiligo and other diseases.”
Chairman of the Medical Board of the National Psoriasis Foundation (term 2002-2014), Dr. Lebwohl is also the founding editor of Psoriasis Forum. He has served on the editorial board of the Journal of the American Academy of Dermatology and of the Journal of Skin Cancer and is editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine.
Dr. Lebwohl has chaired numerous symposia and has written, edited, or co-edited more than 10 books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, as well as the world’s leading book on dermatologic therapy, Treatment of Skin Disease. He has authored or co-authored over 500 publications including peer-reviewed articles, invited articles and book chapters.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.